Age Matching Is Essential for the Study of Cerebrospinal Fluid sTREM2 Levels and Alzheimer’s Disease Risk: A Meta-Analysis

Background: Both the genetic and pathological studies link Alzheimer’s disease (AD) to the triggering receptor expressed on myeloid cells 2 (TREM2). A large number of studies have explored the value of cerebrospinal fluid (CSF) soluble TREM2 (sTREM2) levels as a biomarker for the diagnosis and predi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shimin Hu, Na Pan, Chunyan Liu, Yuping Wang, Tingting Zhang
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/821d46f1b1e748799abb564b67e141c5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:821d46f1b1e748799abb564b67e141c5
record_format dspace
spelling oai:doaj.org-article:821d46f1b1e748799abb564b67e141c52021-11-12T04:45:15ZAge Matching Is Essential for the Study of Cerebrospinal Fluid sTREM2 Levels and Alzheimer’s Disease Risk: A Meta-Analysis1663-436510.3389/fnagi.2021.775432https://doaj.org/article/821d46f1b1e748799abb564b67e141c52021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fnagi.2021.775432/fullhttps://doaj.org/toc/1663-4365Background: Both the genetic and pathological studies link Alzheimer’s disease (AD) to the triggering receptor expressed on myeloid cells 2 (TREM2). A large number of studies have explored the value of cerebrospinal fluid (CSF) soluble TREM2 (sTREM2) levels as a biomarker for the diagnosis and prediction of AD; however, the findings are inconsistent. We aimed to review the studies that investigated the association of CSF sTREM2 levels and AD risk, and to provide the recommendations for future research.Methods and Results: A systematic literature search was performed using the MEDLINE, EMBASE, and Web of Science (all databases) databases. The meta-analysis for the association between the CSF sTREM2 levels and AD risk included 15 studies (17 comparisons) with a total of 1,153 cases and 1,626 controls. The total results showed that the higher CSF sTREM2 levels and AD risk were associated [standardized mean difference (SMD) = 0.428, 95% CI (0.213, 0.643), I2 = 81.1%]. However, the analysis of the subgroup of “age difference ≤ 2 years” indicated that sTREM2 was not associated with AD [SMD = 0.090, 95% CI (−0.092, 0.272), I2 = 27.4%] and had a significantly lower heterogeneity. Combining the results of the “age difference of 5–10 years” [SMD = 0.497, 95% CI (0.139, 0.855), I2 = 82.5%] and “age difference > 10 years” [SMD = 0.747, 95% CI (0.472, 1.023), I2 = 50.0%] subgroups showed that the difference in CSF sTREM2 between the AD and control groups was positively correlated with the age difference. A meta-regression analysis showed that the age difference can explain 33.4% of the between-study variance. By conducting further subgroup analyses of the five age-matched studies (495 cases and 364 controls) according to the measurement method, and whether inclusion criteria containing the requirement for pathological evidence of AD, no changes were observed in the corresponding pooled SMD or in the significance of the results. The meta-analysis result of “age difference ≤ 2 years” group was robust in the sensitivity analysis.Conclusion: The available high-quality evidence does not yet support an association between the CSF sTREM2 levels and AD risk. Age matching between the patients with AD and cognitively unimpaired controls was a major influencing factor in the results.Shimin HuShimin HuNa PanNa PanChunyan LiuChunyan LiuYuping WangYuping WangYuping WangTingting ZhangTingting ZhangFrontiers Media S.A.articleAlzheimer’s diseasesTREM2age matchingmeta-analysiscerebrospinal fluidNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571ENFrontiers in Aging Neuroscience, Vol 13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Alzheimer’s disease
sTREM2
age matching
meta-analysis
cerebrospinal fluid
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
spellingShingle Alzheimer’s disease
sTREM2
age matching
meta-analysis
cerebrospinal fluid
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Shimin Hu
Shimin Hu
Na Pan
Na Pan
Chunyan Liu
Chunyan Liu
Yuping Wang
Yuping Wang
Yuping Wang
Tingting Zhang
Tingting Zhang
Age Matching Is Essential for the Study of Cerebrospinal Fluid sTREM2 Levels and Alzheimer’s Disease Risk: A Meta-Analysis
description Background: Both the genetic and pathological studies link Alzheimer’s disease (AD) to the triggering receptor expressed on myeloid cells 2 (TREM2). A large number of studies have explored the value of cerebrospinal fluid (CSF) soluble TREM2 (sTREM2) levels as a biomarker for the diagnosis and prediction of AD; however, the findings are inconsistent. We aimed to review the studies that investigated the association of CSF sTREM2 levels and AD risk, and to provide the recommendations for future research.Methods and Results: A systematic literature search was performed using the MEDLINE, EMBASE, and Web of Science (all databases) databases. The meta-analysis for the association between the CSF sTREM2 levels and AD risk included 15 studies (17 comparisons) with a total of 1,153 cases and 1,626 controls. The total results showed that the higher CSF sTREM2 levels and AD risk were associated [standardized mean difference (SMD) = 0.428, 95% CI (0.213, 0.643), I2 = 81.1%]. However, the analysis of the subgroup of “age difference ≤ 2 years” indicated that sTREM2 was not associated with AD [SMD = 0.090, 95% CI (−0.092, 0.272), I2 = 27.4%] and had a significantly lower heterogeneity. Combining the results of the “age difference of 5–10 years” [SMD = 0.497, 95% CI (0.139, 0.855), I2 = 82.5%] and “age difference > 10 years” [SMD = 0.747, 95% CI (0.472, 1.023), I2 = 50.0%] subgroups showed that the difference in CSF sTREM2 between the AD and control groups was positively correlated with the age difference. A meta-regression analysis showed that the age difference can explain 33.4% of the between-study variance. By conducting further subgroup analyses of the five age-matched studies (495 cases and 364 controls) according to the measurement method, and whether inclusion criteria containing the requirement for pathological evidence of AD, no changes were observed in the corresponding pooled SMD or in the significance of the results. The meta-analysis result of “age difference ≤ 2 years” group was robust in the sensitivity analysis.Conclusion: The available high-quality evidence does not yet support an association between the CSF sTREM2 levels and AD risk. Age matching between the patients with AD and cognitively unimpaired controls was a major influencing factor in the results.
format article
author Shimin Hu
Shimin Hu
Na Pan
Na Pan
Chunyan Liu
Chunyan Liu
Yuping Wang
Yuping Wang
Yuping Wang
Tingting Zhang
Tingting Zhang
author_facet Shimin Hu
Shimin Hu
Na Pan
Na Pan
Chunyan Liu
Chunyan Liu
Yuping Wang
Yuping Wang
Yuping Wang
Tingting Zhang
Tingting Zhang
author_sort Shimin Hu
title Age Matching Is Essential for the Study of Cerebrospinal Fluid sTREM2 Levels and Alzheimer’s Disease Risk: A Meta-Analysis
title_short Age Matching Is Essential for the Study of Cerebrospinal Fluid sTREM2 Levels and Alzheimer’s Disease Risk: A Meta-Analysis
title_full Age Matching Is Essential for the Study of Cerebrospinal Fluid sTREM2 Levels and Alzheimer’s Disease Risk: A Meta-Analysis
title_fullStr Age Matching Is Essential for the Study of Cerebrospinal Fluid sTREM2 Levels and Alzheimer’s Disease Risk: A Meta-Analysis
title_full_unstemmed Age Matching Is Essential for the Study of Cerebrospinal Fluid sTREM2 Levels and Alzheimer’s Disease Risk: A Meta-Analysis
title_sort age matching is essential for the study of cerebrospinal fluid strem2 levels and alzheimer’s disease risk: a meta-analysis
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/821d46f1b1e748799abb564b67e141c5
work_keys_str_mv AT shiminhu agematchingisessentialforthestudyofcerebrospinalfluidstrem2levelsandalzheimersdiseaseriskametaanalysis
AT shiminhu agematchingisessentialforthestudyofcerebrospinalfluidstrem2levelsandalzheimersdiseaseriskametaanalysis
AT napan agematchingisessentialforthestudyofcerebrospinalfluidstrem2levelsandalzheimersdiseaseriskametaanalysis
AT napan agematchingisessentialforthestudyofcerebrospinalfluidstrem2levelsandalzheimersdiseaseriskametaanalysis
AT chunyanliu agematchingisessentialforthestudyofcerebrospinalfluidstrem2levelsandalzheimersdiseaseriskametaanalysis
AT chunyanliu agematchingisessentialforthestudyofcerebrospinalfluidstrem2levelsandalzheimersdiseaseriskametaanalysis
AT yupingwang agematchingisessentialforthestudyofcerebrospinalfluidstrem2levelsandalzheimersdiseaseriskametaanalysis
AT yupingwang agematchingisessentialforthestudyofcerebrospinalfluidstrem2levelsandalzheimersdiseaseriskametaanalysis
AT yupingwang agematchingisessentialforthestudyofcerebrospinalfluidstrem2levelsandalzheimersdiseaseriskametaanalysis
AT tingtingzhang agematchingisessentialforthestudyofcerebrospinalfluidstrem2levelsandalzheimersdiseaseriskametaanalysis
AT tingtingzhang agematchingisessentialforthestudyofcerebrospinalfluidstrem2levelsandalzheimersdiseaseriskametaanalysis
_version_ 1718431239789084672